Gretchen E. Schlosser Covell, MD
Gretchen E. Schlosser Covell, MD, is a neurologist with expertise in cognitive neurology and the evaluation and management of general neurology issues. Dr. Schlosser Covell is board-certified in Neurology by the American Board of Psychiatry and Neurology and has extensive experience caring for patients with migraine, tremor, Alzheimer’s disease, mild cognitive impairment, and other neurodegenerative conditions. She previously practiced with the Southern California Permanente Medical Group, where she provided comprehensive general neurologic care. In her free time, she participated in initiatives focused on cognitive health screening protocols and dementia care.
Dr. Schlosser Covell has been actively involved in professional and community efforts related to Alzheimer’s disease and cognitive disorders. She served as a member of the Alzheimer’s Project Clinical Roundtable and participated in public education and advocacy activities focused on dementia awareness. Her commitment to patient care has been recognized through multiple honors, including the Southern California Permanente Medical Group Excellence Award and Five-Star Experience Award. She is a member of the American Academy of Neurology.
Dr. Schlosser Covell has contributed to clinical research examining risk factors, biomarkers, and cognitive outcomes associated with mild cognitive impairment and Alzheimer’s disease. Her scholarly work has included studies of physical activity, sleep patterns, metabolic factors, and neuropsychological performance in patients with cognitive decline. She has authored peer-reviewed publications and presented research at national and international scientific meetings.
Dr. Schlosser Covell earned a Bachelor of Arts from Cornell University and received her medical degree from the University of Kentucky College of Medicine. She completed a Transitional Year internship and Neurology residency at Mayo Clinic Arizona.
Research Information
Dr. Schlosser Covell’s research interests focus on QI in satellite clinic operations, cognitive aging, mild cognitive impairment, Alzheimer’s disease, and dementia risk factors. Her work has examined neuropsychological changes associated with early cognitive decline as well as lifestyle and metabolic factors that may influence the development and progression of dementia. She has also studied the relationship between sleep, physical activity, and cognitive health. Through clinical research and patient-centered investigation, Dr. Schlosser Covell seeks to improve the understanding, early identification, and management of neurodegenerative disorders.